A new drug for severe influenza successfully keeps patients at the perfect level of lung inflammation to protect against lung damage, while still allowing the immune system to fight off the infection.

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...

AbbVie secures Canadian support for Skyrizi in ulcerative colitis with new reimbursement recommendations and a completed pCPA agreement.

The COVID-19 pandemic caused by SARS-CoV-2 infection is marked by excessive inflammation of several organs, leading to multi-organ failure. The recognition of the virus by our bodies triggers severe ...

A study in mice and in rabbits suggests that an experimental drug called saracatinib, which has already been tested as a potential treatment for cancer, lung, and Alzheimer’s disease, may slow the ...

For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, the focus for many years. People on the drug also had ...

Ken Hsu and collaborators are working towards a non-addictive painkiller using a novel way to shut off inflammation. An artistic depiction of energy metabolism in cells which is also regulated by ...

The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially life-threatening kidney disease, the health regulator's website showed on Tuesday. The ...

Dr. Lamas, a contributing Opinion writer, is a pulmonary and critical-care physician at Brigham and Women’s Hospital in Boston. In the near future, the story of drugs like Ozempic may no longer be ...

SetPoint therapy is a tiny, pill-sized implant that’s inserted into the body. Metro Phoenix-based Dr. John Tesser served as ...

A huge study shows two popular diabetes drugs also protect the heart. Both lower the risk of heart attack and stroke in real patients.